Cargando…

INCIDENCE OF MAJOR ADVERSE CARDIAC EVENTS AT 6-MONTHS FOLLOW-UP IN COVID-19 POSITIVE VERSUS COVID-19 NEGATIVE PATIENTS

Detalles Bibliográficos
Autores principales:	Arman, Huseyin Emre, Ali, Saad, Colin, Terry, Marks, Jennifer, Raman, Subha V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2023
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982917/ http://dx.doi.org/10.1016/S0735-1097(23)02711-0

Ejemplares similares

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

ELEVATED INTERLEUKIN-6 LEVELS IN COVID-19-INFECTED PATIENTS ARE ASSOCIATED WITH MAJOR ADVERSE CARDIAC EVENTS AND/OR MORTALITY
por: Nguyen, Nicholas, et al.
Publicado: (2021)

PREDICTIVE VALUE OF TROPONIN, NTPROBNP AND SODIUM ON ADVERSE CLINICAL OUTCOMES IN COVID-19
por: Roman, Aida, et al.
Publicado: (2021)

THE INCIDENCE OF CARDIAC ARRHYTHMIAS IN PATIENTS WITH COVID-19: A META-ANALYSIS
por: Kim, Sean, et al.
Publicado: (2022)

CORONARY ARTERY CALCIFICATION HERALDS ADVERSE CLINICAL OUTCOMES IN PATIENTS HOSPITALIZED FOR COVID-19
por: Shabbir, Muhammad Asim, et al.
Publicado: (2021)

AORTIC VALVE PROSTHESES, ICDS, AND CORONARY DRUG-ELUTING STENTS: CHANGES IN REPORTED RATES OF ADVERSE EVENTS DURING THE COVID-19 PANDEMIC
por: Zhou, Elsa, et al.
Publicado: (2022)

INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC CHANGES IN ETHNIC MINORITY PATIENTS WITH COVID- 19 INFECTION
por: Jadhav, Preeti, et al.
Publicado: (2021)

HEART RATE VARIABILITY IS REDUCED 3- AND 6-MONTHS AFTER HOSPITALIZATION FOR COVID-19 INFECTION
por: Adler, Tessa E., et al.
Publicado: (2021)

CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2022)

A SYSTEMATIC REVIEW AND META ANALYSIS OF THE EVIDENCE FROM THE PUBLISHED CASE REPORTS AND VACCINE ADVERSE EVENTS REPORTING SYSTEMS FOR THE MYOCARDITIS FOLLOWING COVID-19 VACCINATION
por: Mehta, Ashwani, et al.
Publicado: (2022)

CORONARY MICROVASCULAR HEALTH IN PATIENTS WITH PRIOR COVID-19 INFECTION: IMPLICATIONS FOR LONG-COVID SYNDROME
por: Ahmed, Ahmed Ibrahim, et al.
Publicado: (2022)

CARDIOVASCULAR PREDICTORS OF ADVERSE OUTCOMES IN RACIALLY DIVERSE PATIENTS DIAGNOSED WITH COVID-19 INFECTION - AN EARLY, INNER CITY EXPERIENCE
por: Quelal, Karol, et al.
Publicado: (2021)

CLINICAL PREDICTORS OF COAGULOPATHY EVENTS IN HOSPITALIZED PATIENTS WITH COVID-19 DISEASE
por: Derbas, Laith, et al.
Publicado: (2021)

OUTPATIENT CARDIAC MONITORING TO DETERMINE ARRHYTHMIC BURDEN AFTER COVID-19 HOSPITALIZATION
por: Beccarino, Nicholas, et al.
Publicado: (2022)

IMAGING AND METABOLIC STRESS FINDINGS IN COLLEGE ATHLETES RECOVERING FROM COVID-19 INFECTION
por: Ullah, Muhammad Wajih, et al.
Publicado: (2022)

BIOMARKERS OF INFLAMMATION AND OUTCOMES OF PATIENTS HOSPITALIZED FOR COVID-19: THE INTERNATIONAL STUDY OF INFLAMMATION IN COVID-19
por: Meloche, Chelsea, et al.
Publicado: (2021)

NATIONWIDE TEMPORAL EVOLUTION OF PRE-HOSPITAL CARDIAC EVENTS DURING THE COVID-19 PANDEMIC
por: Shekhar, Aditya, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE
por: Moey, Melissa YY, et al.
Publicado: (2021)

OBESITY, INFLAMMATION, AND OUTCOMES IN COVID-19
por: Padalia, Kishan, et al.
Publicado: (2021)

WHO IS AT RISK FOR CARDIOMYOPATHY IN COVID 19
por: Daftari, Diana, et al.
Publicado: (2021)

BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
por: Hoang, Lawrence, et al.
Publicado: (2021)

THE EFFECT OF COVID-19 ON CARDIOVASCULAR PRODUCERS
por: Annie, Frank H., et al.
Publicado: (2021)

CATHETER-DIRECTED THROMBOLYSIS IN COVID-19
por: Ammar, Ali, et al.
Publicado: (2022)

COVID-19 PANDEMIC STRESS CAN TRIGGER ACUTE CARDIOVASCULAR EVENTS IN NON-INFECTED INDIVIDUALS
por: Hammoudeh, Ayman J., et al.
Publicado: (2021)

OUTCOMES OF PATIENTS WITH PULMONARY EMBOLISM WITH HISTORY OF COVID-19 ARE AS POOR AS PATIENTS WITH PULMONARY EMBOLISM WITH SEVERE COVID-19
por: Ho, Timothy D., et al.
Publicado: (2022)

THE CARDIONERDS CASE REPORT SERIES: CONNECTING THE CARDIOLOGY COMMUNITY DURING THE COVID-19 PANDEMIC
por: Desai, Karan, et al.
Publicado: (2021)

REDUCTION IN HOSPITAL ADMISSIONS ASSOCIATED WITH CORONARY EVENTS DURING THE COVID-19 PANDEMIC IN THE BRAZILIAN PRIVATE HEALTH
por: Nascimento, Bruno Ramos, et al.
Publicado: (2021)

IMPACT OF THE COVID-19 PANDEMIC ON HOSPITAL ADMISSIONS AND MORTALITY ASSOCIATED WITH CORONARY EVENTS IN THE BRAZILIAN PRIVATE HEALTH
por: Nascimento, Bruno Ramos, et al.
Publicado: (2022)

OUTCOMES OF COVID-19 IN PATIENTS WITH CARDIOVASCULAR DISEASE
por: Vu, Chau N., et al.
Publicado: (2021)

EFFECT OF STATIN IN HOSPITALIZED PATIENTS WITH COVID 19
por: Bonilla, Hilda Mariana Gonzalez, et al.
Publicado: (2021)

CARDIAC ABNORMALITIES IN COVID-19 AND RELATIONSHIP TO OUTCOME
por: Krishna, Hema, et al.
Publicado: (2021)

RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
por: Holmes, Adam R., et al.
Publicado: (2021)

TROPONIN CORRELATES WITH INFLAMMATORY MARKERS IN COVID-19
por: Klinkhammer, Brent, et al.
Publicado: (2021)

TAKOTSUBO SYNDROME FROM COVID-19 INFECTION
por: Kanelidis, Anthony, et al.
Publicado: (2022)

CLINICAL CHARACTERISTICS OF NEUROLOGICAL DISEASE AND COVID-19
por: Thakkar, Kajal, et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022)

INFLAMMATION AND VASCULAR REMODELING IN COVID-19 HEARTS
por: Werlein, Christopher, et al.
Publicado: (2022)

TREATMENT OF MECHANICAL COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION DURING THE COVID-19 ERA: A COMPARISON WITH THE PRE-COVID-19 PERIOD
por: Spadaccio, Cristiano, et al.
Publicado: (2022)

COVID-19 AND HEART: ASSESSMENT OF TROPONIN AND CARDIOVASCULAR COMORBIDITIES AS PROGNOSTIC MARKERS IN PATIENTS HOSPITALIZED FOR COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Pinesi, Henrique, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rht4osbn3c1qgh89925i708l1s